• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估慢性阻塞性肺疾病(COPD)患者自我报告的身体活动水平:使用行为危险因素监测系统网络分析工具(BRFSS-WEAT)数据进行的综合分析。

Assessing Self-Reported Physical Activity Levels in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Comprehensive Analysis Using the Behavioral Risk Factor Surveillance System-Web Enabled Analysis Tool (BRFSS-WEAT) Data.

作者信息

De Vos Jacques, Nair Shruti, Mathew Tim, Patel Mehulkumar M, Kaka Manaswini Chowdary

机构信息

Internal Medicine, Stellenbosch University, Cape Town, ZAF.

General Surgery, Lourdes Hospital, Kochi, IND.

出版信息

Cureus. 2025 Jun 17;17(6):e86206. doi: 10.7759/cureus.86206. eCollection 2025 Jun.

DOI:10.7759/cureus.86206
PMID:40677446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12269525/
Abstract

Background Chronic obstructive pulmonary disease (COPD) includes chronic bronchitis and emphysema and is characterized by persistent airflow limitation. It is caused by long-term exposure to harmful particles or gases, leading to significant breathing difficulties and substantially impacting quality of life. Understanding the complexity and socioeconomic burden of COPD is vital for improving patient outcomes and addressing broader implications. This study assesses the self-reported physical activity levels of COPD patients in the United States using the 2021 Behavioral Risk Factor Surveillance System (BRFSS) data, exploring the impact of demographic, socioeconomic, and healthcare access variables. Methodology The 2021 BRFSS data were analysed, focusing on 34,061 individuals diagnosed with COPD, emphysema, or chronic bronchitis. Fisher's exact test and the chi-square test were used to examine associations between self-reported physical activity levels and demographic (age, gender, race), socioeconomic (education, employment, income), and healthcare access (last routine check-up) variables, with 95% confidence intervals. Results Of the 435,780 BRFSS participants, 7.8% reported having COPD. Among these, 55% engaged in physical activity compared to 77.4% of non-COPD individuals. Physical activity levels were significantly lower among COPD patients (p < 0.001), with notable variations across age groups, genders, races, education levels, employment statuses, income categories, and time since the last routine check-up. Conclusions The findings reveal a significant disparity in physical activity between COPD patients and non-COPD individuals. These findings highlight the need for targeted interventions to improve physical activity among COPD patients to enhance their health outcomes and quality of life.

摘要

背景 慢性阻塞性肺疾病(COPD)包括慢性支气管炎和肺气肿,其特征为持续性气流受限。它是由长期接触有害颗粒或气体引起的,会导致严重的呼吸困难,并对生活质量产生重大影响。了解COPD的复杂性和社会经济负担对于改善患者预后及应对更广泛的影响至关重要。本研究使用2021年行为危险因素监测系统(BRFSS)数据评估了美国COPD患者自我报告的身体活动水平,探讨了人口统计学、社会经济和医疗保健可及性变量的影响。方法 对2021年BRFSS数据进行了分析,重点关注34061名被诊断患有COPD、肺气肿或慢性支气管炎的个体。采用费舍尔精确检验和卡方检验来检验自我报告的身体活动水平与人口统计学(年龄、性别、种族)、社会经济(教育、就业、收入)和医疗保健可及性(上次定期体检)变量之间的关联,并给出95%置信区间。结果 在435780名BRFSS参与者中,7.8%报告患有COPD。其中,55%的人进行身体活动,而非COPD个体的这一比例为77.4%。COPD患者的身体活动水平显著较低(p<0.001),在年龄组、性别、种族、教育水平、就业状况、收入类别以及上次定期体检后的时间等方面存在显著差异。结论 研究结果显示COPD患者与非COPD个体在身体活动方面存在显著差异。这些发现凸显了采取针对性干预措施以提高COPD患者身体活动水平从而改善其健康结局和生活质量的必要性。

相似文献

1
Assessing Self-Reported Physical Activity Levels in Chronic Obstructive Pulmonary Disease (COPD) Patients: A Comprehensive Analysis Using the Behavioral Risk Factor Surveillance System-Web Enabled Analysis Tool (BRFSS-WEAT) Data.评估慢性阻塞性肺疾病(COPD)患者自我报告的身体活动水平:使用行为危险因素监测系统网络分析工具(BRFSS-WEAT)数据进行的综合分析。
Cureus. 2025 Jun 17;17(6):e86206. doi: 10.7759/cureus.86206. eCollection 2025 Jun.
2
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.
3
Telehealth interventions: remote monitoring and consultations for people with chronic obstructive pulmonary disease (COPD).远程医疗干预:针对慢性阻塞性肺疾病(COPD)患者的远程监测和咨询。
Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD013196. doi: 10.1002/14651858.CD013196.pub2.
4
Self-management interventions for people with chronic obstructive pulmonary disease.针对慢性阻塞性肺疾病患者的自我管理干预措施。
Cochrane Database Syst Rev. 2022 Jan 10;1(1):CD002990. doi: 10.1002/14651858.CD002990.pub4.
5
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.免疫刺激剂与安慰剂在预防慢性支气管炎或慢性阻塞性肺疾病成人恶化中的比较。
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2.
6
Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).干预措施以提高慢性阻塞性肺疾病(COPD)药物治疗的依从性。
Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD013381. doi: 10.1002/14651858.CD013381.pub2.
7
Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者自我管理干预措施(包括针对病情加重的行动计划)与常规护理的比较。
Cochrane Database Syst Rev. 2017 Aug 4;8(8):CD011682. doi: 10.1002/14651858.CD011682.pub2.
8
Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease.噻托溴铵与长效β受体激动剂治疗稳定期慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD009157. doi: 10.1002/14651858.CD009157.pub2.
9
Psychological therapies for the treatment of anxiety disorders in chronic obstructive pulmonary disease.用于治疗慢性阻塞性肺疾病焦虑症的心理疗法。
Cochrane Database Syst Rev. 2017 Mar 21;3(3):CD010673. doi: 10.1002/14651858.CD010673.pub2.
10
Sexual Harassment and Prevention Training性骚扰与预防培训

本文引用的文献

1
Prevalence and prognostic importance of exercise limitation and physical inactivity in COPD.慢性阻塞性肺疾病(COPD)中运动受限和身体活动不足的患病率及预后重要性
Breathe (Sheff). 2024 Jun 11;20(2):230179. doi: 10.1183/20734735.0179-2023. eCollection 2024 Jun.
2
Physical Activity, Depression and Quality of Life in COPD - Results from the CLARA II Study.COPD 患者的体力活动、抑郁与生活质量 - CLARA II 研究结果。
Int J Chron Obstruct Pulmon Dis. 2023 Nov 29;18:2755-2767. doi: 10.2147/COPD.S435278. eCollection 2023.
3
Trends in the Prevalence of Chronic Obstructive Pulmonary Disease Among Adults Aged ≥18 Years - United States, 2011-2021.成年人中≥18 岁慢性阻塞性肺疾病患病率趋势-美国,2011-2021 年。
MMWR Morb Mortal Wkly Rep. 2023 Nov 17;72(46):1250-1256. doi: 10.15585/mmwr.mm7246a1.
4
Analysing the Effects of Different Types of Exercise on Dyspnoea and Fatigue in Adults through COPD-Systematic Review and Meta-Analysis of Randomised Clinical Trials.通过对随机临床试验的系统评价和荟萃分析,分析不同类型运动对慢性阻塞性肺疾病(COPD)成人患者呼吸困难和疲劳的影响。
Healthcare (Basel). 2023 May 16;11(10):1449. doi: 10.3390/healthcare11101449.
5
Effects of exercise-based pulmonary rehabilitation on severe/very severe COPD: a systematic review and meta-analysis.基于运动的肺康复对严重/极重度 COPD 的影响:系统评价和荟萃分析。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231162250. doi: 10.1177/17534666231162250.
6
Exercise rehabilitation in COPD and heart failure: comparison of two national audits.慢性阻塞性肺疾病和心力衰竭的运动康复:两项全国性审计的比较
ERJ Open Res. 2022 Nov 28;8(4). doi: 10.1183/23120541.00131-2022. eCollection 2022 Oct.
7
The ability of physical activity in reducing mortality risks and cardiovascular loading and in extending life expectancy in patients with COPD.体力活动在降低 COPD 患者死亡率和心血管负荷以及延长预期寿命方面的能力。
Sci Rep. 2021 Nov 4;11(1):21674. doi: 10.1038/s41598-021-00728-2.
8
Molecular markers of aging, exercise capacity, & physical activity in COPD.衰老、运动能力和 COPD 中的体力活动的分子标志物。
Respir Med. 2021 Oct;187:106576. doi: 10.1016/j.rmed.2021.106576. Epub 2021 Aug 14.
9
Improving Exercise-Based Interventions for People Living with Both COPD and Frailty: A Realist Review.改善 COPD 合并衰弱患者的运动干预措施:一项现实主义综述。
Int J Chron Obstruct Pulmon Dis. 2020 Apr 20;15:841-855. doi: 10.2147/COPD.S238680. eCollection 2020.
10
Exercise and Chronic Obstructive Pulmonary Disease (COPD).运动与慢性阻塞性肺疾病(COPD)。
Adv Exp Med Biol. 2020;1228:355-368. doi: 10.1007/978-981-15-1792-1_24.